These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 18892

  • 1. Effect of dopaminephilic agents and cAMP on tyrosine hydroxylase activity.
    Goldstein M, Bronaugh RL, Lew JU, Ohashi T, Drummond GS, Fuxe K.
    Adv Biochem Psychopharmacol; 1977; 16():447-53. PubMed ID: 18892
    [No Abstract] [Full Text] [Related]

  • 2. Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase.
    Strait KA, Kuczenski R.
    Mol Pharmacol; 1986 Jun; 29(6):561-9. PubMed ID: 2872588
    [Abstract] [Full Text] [Related]

  • 3. [Effect of the atypical neuroleptics karbidin and sulpiride on the synaptosomal tyrosine hydroxylase of the corpus striatum of rats].
    Meos AA, Kudrin VS, Raevskiĭ KS.
    Biull Eksp Biol Med; 1984 Sep; 98(9):305-8. PubMed ID: 6148973
    [Abstract] [Full Text] [Related]

  • 4. [Effect of the atypical neuroleptics carbidine and sulpiride on dopamine biosynthesis in the synaptosomes of the nucleus accumbens septi in rats].
    Kudrin VS, Hetey L, Morgenshtern R, Raevskiĭ KS, Olssner W.
    Farmakol Toksikol; 1987 Sep; 50(2):16-20. PubMed ID: 2884129
    [Abstract] [Full Text] [Related]

  • 5. Dopaminephilic properties of ergot alkaloids.
    Goldstein M, Lew JY, Nakamura S, Battista AF, Lieberman A, Fuxe K.
    Fed Proc; 1978 Jun; 37(8):2202-6. PubMed ID: 26607
    [No Abstract] [Full Text] [Related]

  • 6. The effect of various chlorpromazine derivatives on the apomorphine-elicited inhibition of synaptosomal tyrosine hydroxylase activity.
    Bronaugh RL, Goldstein M.
    Psychopharmacol Commun; 1975 Jun; 1(2):201-8. PubMed ID: 4859
    [Abstract] [Full Text] [Related]

  • 7. Activation by cyclic 3':5'-adenosine monophosphate of tyrosine hydroxylase in the rat brain.
    Harris JE, Baldessarini RJ, Morgenroth VH, Roth RH.
    Proc Natl Acad Sci U S A; 1975 Mar; 72(3):789-93. PubMed ID: 236558
    [Abstract] [Full Text] [Related]

  • 8. The effect of dopamine and of apomorphine on dB-cAMP induced stimulation of synaptosomal tyrosine hydroxylase.
    Ebstein B, Roberge C, Tabachnick J, Goldstein M.
    J Pharm Pharmacol; 1974 Dec; 26(12):975-7. PubMed ID: 4156865
    [No Abstract] [Full Text] [Related]

  • 9. Regulatory mechanisms of dopamine biosynthesis at the tyrosine hydroxylase step.
    Goldstein M.
    Ann N Y Acad Sci; 1984 Dec; 430():1-5. PubMed ID: 6146282
    [No Abstract] [Full Text] [Related]

  • 10. Binding interactions of ergot alkaloids with monoaminergic receptors in the brain.
    Goldstein M, Lew JY, Hata F, Lieberman A.
    Gerontology; 1978 Dec; 24 Suppl 1():76-85. PubMed ID: 22480
    [Abstract] [Full Text] [Related]

  • 11. The effect of butaclamol and of other neuroleptic agents on the apomorphine-elicited inhibition of synaptosomal tyrosine hydroxylase activity.
    Bronaugh RL, Tabak J, Ohashi T, Goldstein M.
    Psychopharmacol Commun; 1975 Dec; 1(5):501-10. PubMed ID: 7003
    [Abstract] [Full Text] [Related]

  • 12. Striatal synaptosomal tyrosine hydroxylase activity. A model system for study of presynaptic dopamine receptors.
    McMillen BA.
    Biochem Pharmacol; 1982 Aug 15; 31(16):2643-7. PubMed ID: 6128002
    [Abstract] [Full Text] [Related]

  • 13. Presynaptic regulation of tyrosine hydroxylase activity in rat striatal synaptosomes by dopamine analogs.
    Waggoner WG, McDermed J, Leighton HJ.
    Mol Pharmacol; 1980 Jul 15; 18(1):91-9. PubMed ID: 6106156
    [No Abstract] [Full Text] [Related]

  • 14. Stimulation of tyrosine hydroxylase activity by cyclic AMP in synaptosomes and in soluble striatal enzyme preparations.
    Goldstein M, Bronaugh RL, Ebstein B, Roberge C.
    Brain Res; 1976 Jun 18; 109(3):563-74. PubMed ID: 6124
    [Abstract] [Full Text] [Related]

  • 15. [Ratio of brain synaptosome Na, K-ATPase to dopamine receptors].
    Glebov RN, Zholob GI, Komissarov IV.
    Biull Eksp Biol Med; 1987 Oct 18; 104(10):430-2. PubMed ID: 2890383
    [Abstract] [Full Text] [Related]

  • 16. Effect of dopaminergic agonists and antagonists on in vivo cyclic nucleotide content: relation of guanosine 3':5'- monophosphate (cGMP) changes in cerebellum to behavior.
    Breese GR, Mueller RA, Mailman RB.
    J Pharmacol Exp Ther; 1979 May 18; 209(2):262-70. PubMed ID: 35602
    [No Abstract] [Full Text] [Related]

  • 17. Putative interaction of presynaptic dopamine and serotonin receptors modulating synaptosomal tyrosine hydroxylase activity in the nucleus accumbens of rats.
    Hetey L.
    Biomed Biochim Acta; 1988 May 18; 47(12):1089-92. PubMed ID: 2908173
    [Abstract] [Full Text] [Related]

  • 18. Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis.
    Fuxe K, Fredholm BB, Ogren SO, Agnati LF, Hökfelt T, Gustafsson JA.
    Fed Proc; 1978 Jun 18; 37(8):2181-91. PubMed ID: 350633
    [Abstract] [Full Text] [Related]

  • 19. Effects of BMY 14802, a potential antipsychotic drug, on rat brain dopaminergic function.
    Matthews RT, McMillen BA, Sallis R, Blair D.
    J Pharmacol Exp Ther; 1986 Oct 18; 239(1):124-31. PubMed ID: 2876091
    [Abstract] [Full Text] [Related]

  • 20. Effects of chronic neuroleptic treatment on tyrosine hydroxylase in dopaminergic terminals: comparisons between drugs and brain regions reveals different mechanisms of tolerance.
    Gale K.
    Adv Biochem Psychopharmacol; 1980 Oct 18; 24():23-9. PubMed ID: 6105777
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.